Published On: Mon, May 22nd, 2017

Broker Changes For ICON Plc (NASDAQ:ICLR)


Recently stock market analysts have updated their consensus ratings on shares of ICON plc (NASDAQ:ICLR).

Most recent broker ratings

04/27/2017 – ICON plc had its “outperform” rating reiterated by analysts at Evercore ISI. They now have a USD 92 price target on the stock.

03/23/2017 – Mizuho began new coverage on ICON plc giving the company a “neutral” rating. They now have a USD 86 price target on the stock.

02/17/2017 – ICON plc had its “buy” rating reiterated by analysts at UBS. They now have a USD 105 price target on the stock.

01/24/2017 – ICON plc had its “hold” rating reiterated by analysts at Jefferies. They now have a USD 86 price target on the stock.

12/16/2016 – ICON plc was downgraded to “hold” by analysts at SunTrust. They now have a USD 80 price target on the stock.

12/16/2016 – ICON plc was upgraded to “buy” by analysts at Goldman Sachs. They now have a USD 90 price target on the stock.

10/20/2016 – ICON plc had its “mkt perform” rating reiterated by analysts at Avondale Partners.

06/24/2016 – ICON plc had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 83 price target on the stock.

06/20/2016 – Credit Suisse began new coverage on ICON plc giving the company a “outperform” rating. They now have a USD 80 price target on the stock.

07/29/2015 – ICON plc had its “overweight” rating reiterated by analysts at KeyBanc. They now have a USD 85 price target on the stock.

04/24/2015 – ICON plc had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 70 price target on the stock.

03/10/2015 – ICON plc was upgraded to “outperform” by analysts at Zacks. They now have a USD 70.4 price target on the stock.

10/23/2014 – ICON plc was downgraded to “equal weight” by analysts at First Analysis.

08/01/2014 – ICON plc had its “neutral” rating reiterated by analysts at Sterne Agee. They now have a USD 57 price target on the stock.

05/30/2014 – Raymond James began new coverage on ICON plc giving the company a “market perform” rating.

ICON plc has a 50 day moving average of 82.79 and a 200 day moving average of 80.57. The stock’s market capitalization is 4.84B, it has a 52-week low of 63.91 and a 52-week high of 90.55.

The share price of the company (NASDAQ:ICLR) was up +2.62% during the last trading session, with a high of 90.55 and the volume of ICON plc shares traded was 605106.

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company’s information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient’s blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.